Cervical Myelopathy (Spondylotic)

Cervical Spondylotic Myelopathy (CSM): A Comprehensive Clinical Guide

Cervical Spondylotic Myelopathy (CSM) represents the most common cause of spinal cord dysfunction in patients older than 55 years of age. Unlike radiculopathy, which involves compression of the cervical nerve roots, CSM is defined by the compression of the spinal cord itself due to degenerative changes in the cervical spine. As a progressive, non-traumatic condition, it requires a high index of clinical suspicion, as early intervention is the primary determinant of long-term neurological outcomes.

1. Clinical Definition and Etiology

Cervical Spondylotic Myelopathy is a clinical syndrome characterized by spinal cord dysfunction caused by age-related degeneration of the cervical spine. It involves a "double-crush" or cumulative mechanical impact on the spinal cord, leading to both direct compression and secondary ischemic changes.

Primary Etiological Factors

• Disc Degeneration: Desiccation and loss of height in the intervertebral discs lead to bulging and potential herniation.
• Osteophyte Formation: Reactive bone growth at the uncovertebral joints (Luschka) and facet joints narrows the neural foramina and the spinal canal.
• Ligamentous Hypertrophy: Thickening and ossification of the posterior longitudinal ligament (OPLL) or ligamentum flavum further encroaches upon the spinal canal space.
• Congenital Spinal Stenosis: Patients with a narrow sagittal diameter of the cervical canal (<12mm) are predisposed to developing symptomatic myelopathy earlier than those with a standard canal diameter.

2. Pathophysiology: The Mechanics of Cord Injury

The pathophysiology of CSM is multifactorial, involving both static mechanical compression and dynamic factors that exacerbate cord injury over time.

The spinal cord undergoes a process of gliosis and demyelination, particularly in the lateral corticospinal tracts, which manifests as the classic clinical presentation of upper and lower motor neuron signs.

3. Clinical Staging and Grading

To standardize care and prognosis, clinicians utilize the Modified Japanese Orthopaedic Association (mJOA) scale. This is the gold standard for assessing the severity of CSM.

The Modified JOA Scale (mJOA)

The mJOA score ranges from 0 to 18, with higher scores indicating better function.

Severity Grading:
* Mild: mJOA 15–17
* Moderate: mJOA 12–14
* Severe: mJOA < 12

4. Standard Clinical Presentation

Patients with CSM rarely present with pain as the primary complaint. Instead, they present with functional decline.

• Hand Dysfunction: Patients often report "clumsiness." Difficulty with fine motor tasks (buttoning shirts, handwriting, typing) is a hallmark sign.
• Gait Instability: Patients describe a feeling of unsteadiness or "walking on a boat."
• Lhermitte’s Sign: An electric-shock sensation radiating down the spine upon neck flexion.
• Hyperreflexia: Exaggerated deep tendon reflexes in the lower extremities.
• Pathological Reflexes: Presence of Babinski sign or Hoffman’s sign.
• Sensory Changes: Often described as "glove and stocking" paresthesia, though these are typically subtle.

5. Differential Diagnosis

Distinguishing CSM from other neurological conditions is critical to prevent misdiagnosis and inappropriate treatment.

1. Amyotrophic Lateral Sclerosis (ALS): ALS presents with widespread upper and lower motor neuron signs but lacks the sensory deficits and imaging findings of CSM.
2. Multiple Sclerosis (MS): Often presents with intermittent symptoms and disseminated white matter lesions on MRI.
3. Vitamin B12 Deficiency (Subacute Combined Degeneration): Presents with ataxia and sensory loss; must be ruled out via blood work.
4. Lumbar Spinal Stenosis: May coexist with CSM (Tandem Spinal Stenosis).
5. Parkinson’s Disease: Can present with gait disturbances, but lacks the hyperreflexia and sensory findings of CSM.

6. Key Diagnostic Tests

Imaging Modalities

• MRI (The Gold Standard): Provides the most detailed view of the spinal cord. Look for T2-weighted signal hyperintensity (indicating cord edema or myelomalacia) and T1-weighted hypointensity (indicating irreversible gliosis).
• CT Myelography: Indicated for patients who cannot undergo MRI (e.g., patients with non-compatible pacemakers).
• Dynamic Flexion/Extension Radiographs: Used to assess spinal instability.

Electrophysiology

• Somatosensory Evoked Potentials (SSEP): Useful in assessing the functional integrity of the dorsal columns.
• Motor Evoked Potentials (MEP): Used to assess the corticospinal tract function.

7. Risks, Contraindications, and Prognosis

Risks of Non-Intervention

CSM is a progressive condition. Without decompression, the majority of patients will experience a "step-wise" decline in neurological function. Spontaneous recovery is rare.

Contraindications for Surgery

• Severe systemic comorbidities making the patient an unacceptable risk for anesthesia.
• Advanced age with minimal symptoms and stable disease (conservative management may be considered).

Long-term Prognosis

Prognosis is heavily dependent on the duration of symptoms before surgery. Patients with symptoms lasting longer than 12–24 months often show poorer recovery due to established neuronal cell death. Surgery is generally aimed at "preventing further decline" rather than "curing" the existing neurological deficits.

8. Frequently Asked Questions (FAQ)

1. Is CSM always painful?

No. Pain is secondary. The most common presenting symptoms are functional deficits like loss of dexterity and gait instability.

2. Can physical therapy cure CSM?

Physical therapy can assist in balance and gait training but cannot reverse the mechanical compression of the spinal cord. It is generally not considered a primary treatment for moderate-to-severe CSM.

3. What does "signal change" on an MRI mean?

T2-weighted hyperintensity in the spinal cord suggests edema or myelomalacia. It is a prognostic indicator; significant signal change is often associated with a less favorable surgical outcome.

4. How quickly does CSM progress?

Progression is variable. Some patients remain stable for years, while others experience rapid decline. Due to this unpredictability, surgical decompression is often recommended once diagnosis is confirmed.

5. Is surgery risky?

Cervical spine surgery is highly specialized. Risks include dural tear, infection, nerve root injury, and complications related to hardware placement. However, the risk of untreated myelopathy usually outweighs the surgical risk.

6. What is the difference between Radiculopathy and Myelopathy?

Radiculopathy involves a pinched nerve root (pain/numbness in the arm), while Myelopathy involves the spinal cord (global weakness, balance issues, and dexterity loss).

7. Can I "pop" my neck if I have CSM?

Patients with known myelopathy should avoid aggressive chiropractic manipulation of the neck, as it can exacerbate spinal cord compression and lead to acute neurological catastrophe.

8. Will surgery return me to 100% normal?

Likely not. The goal of surgery is decompression to prevent further damage. While many patients see significant functional improvement, some neurological deficits may persist.

9. What is the "Tandem" condition?

Tandem spinal stenosis refers to the simultaneous presence of cervical myelopathy and lumbar spinal stenosis, which can complicate the clinical picture and gait assessment.

10. Does age affect my surgical options?

Age is a factor, but not an absolute contraindication. Modern surgical techniques allow for safe decompression in elderly patients, provided their cardiovascular and pulmonary status is optimized.

9. Conclusion

Cervical Spondylotic Myelopathy is a serious, progressive condition that requires early identification and expert management. Clinical evaluation focusing on fine motor skills, gait, and reflex testing is paramount. With the aid of high-resolution MRI and the mJOA grading system, clinicians can effectively stratify patients for surgical intervention, which remains the definitive treatment to halt neurological deterioration and preserve the patient’s quality of life.

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult with a board-certified orthopedic or neurosurgical specialist for clinical diagnosis and management.

Related Clinical Integration

In the management of Cervical Myelopathy (Spondylotic), a multidisciplinary approach is essential to address both the underlying neurological compression and the associated neuropathic or nociceptive pain profiles. While surgical decompression remains the definitive treatment for progressive neurological deficits, pharmacological intervention is frequently utilized to manage secondary symptoms and improve patient quality of life. Clinicians often prescribe neuropathic pain modulators such as Gabapentin / جابابنتين 300 mg, Neurontin / نيورونتين 600mg, Lyrica / ليريكا 75mg, or Lyrolin (Pregabalin) / ليرولين (بريغابالين) 75mg to mitigate radicular pain and sensory disturbances resulting from spinal cord or nerve root irritation. Furthermore, for patients experiencing acute exacerbations or persistent discomfort, Analgesics (e.g., Acetaminophen, Opioids) / مسكنات الألم (مثل: أسيتامينوفين، الأفيونات) Standard may be integrated into the therapeutic regimen, provided they are administered under strict clinical supervision to balance efficacy with the risks associated with long-term use in a hospital setting.